Haematologica (2012) 97(9):136471
New AI-based research reveals GLP-1 side effects missed in clinical trials New AI-based research showed there may be some side effects from taking a GLP-1 that are being missed in clinical trials
This has a hexameric (6-copy) structure built from right-handed 4-helix bundles, each containing N-terminal hooks that chelate a Ni ion
The idea is to support the bodys natural production instead of depending only on supplements
The study did not exclude any specific brand of drugs, but since Wegovy was only approved in Canada in November 2021, primarily for weight loss, it is likely the bulk of semaglutide users in the study were taking Ozempic, which is prescribed for diabetes
This can lead to symptoms such as feeling sick, throwing up, tiredness, loss of appetite, muscle cramps, itching, and changes in mental function